• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 37 -4 (78) 2025 - Mustafaeva M.R. - PREDICTION OF THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CONTRAST-INDUCED NEPHROPATHY

37 -4 (78) 2025 - Mustafaeva M.R. - PREDICTION OF THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CONTRAST-INDUCED NEPHROPATHY

PREDICTION OF THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CONTRAST-INDUCED NEPHROPATHY

Mustafaeva M.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Chronic kidney injury (CKI) is a chronic impairment of kidney function due to intravenous administration of iodinated contrast agents and most commonly occurs after coronary angiography, percutaneous coronary intervention, and contrast-enhanced computed tomography. The development of CKI is associated with worsening of chronic kidney disease, need for dialysis, prolonged hospital stay, increased mortality, and increased healthcare costs. Several recent studies have shown that exposure to contrast agents may not be the cause of CKI, especially in stable patients who receive low to moderate doses of contrast agents. However, patients undergoing coronary angiography and intervention are indeed at increased risk of CKI due to significant exposure to contrast agents, as well as the presence of concomitant risk factors.

Keywords: chronic kidney disease, contrast nephropathy, coronary angiography, angiography, contrast agent.

First page

224

Last page

228

For citation:Mustafaeva M.R. - PREDICTION OF THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CONTRAST-INDUCED NEPHROPATHY//New Day in Medicine 4(78)2025 224-228 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. Sharipovna A.N., Baxodirovich Ye.B., Otaevna N.X., Avazxonovna S.G. (2021). Surunkali kasalliklarning xavf omillarining paydo bo‘lish chastotasi va tarqalishi bo‘yicha tadqiqot natijalarini tahlil qilish. // International Journal of Current Research and Review, 2021;13(2):127-131. doi10.31782/IJCRR.2021.13232
  2. Olimova G.Sh. O‘smirlarda surunkali buyrak kasalligining erta xavf omillarini aniqlash. //Asian journal of Pharmaceutical and biological research. 2020;12(2):3-9. https://ajpbr.org/index.
  3. Azzalini L, Spagnoli V, Ly HQ. Kontrastli nefropatiya: patofiziologiyadan profilaktika strategiyalarigacha. Can J Cardiol 2015;32:247-55.
  4. Surunkali buyrak kasalligini bashoratlash jihatlari.
  5. Axmedova Nilufar Sharipovna, Ravshanov Sardor Sharipovich Shifoxona sharoitlari. "Biologiya va integrativ tibbiyot" elektron ilmiy jurnali 2022;2(55).
  6. Azzalini L, Garcia-Moll X. On contrast-induced chronic kidney injury, risk prediction, and the future of predictive model development. // Can J Kardiol 2017;33:711-3.
  7. Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. // J Am Soc Nephrol 2017;28:653-9.
  8. Inohara T, Kohsaka S, Miyata H va boshqalar. Amalga oshirish va tasdiqlash Yaponiyada AQSH NCDR surunkali buyrak shikastlanishini bashorat qilish modeli. // J Am Koll Kardiol 2016;67:1715-22.
  9. Andò G, Cortese B, Russo F va boshqalar. Surunkali koronar sindromni invaziv davolash uchun bilak yoki son suyagi orqali kirishdan keyin buyrakning surunkali shikastlanishi: CKI- MATRIX. J Am Coll Cardiol 2017;69:2592-603.
  10. O‘zturk D, Celik O, Erturk M va boshqalar. Birlamchi teri orqali koronar aralashuvdan keyin kontrastli nefropatiyani bashorat qilishda logistik klinik sintaksis ballining foydaliligi. // Can J Cardiol 2016;32:240-6.
  11. Nijssen EC, Rennenberg RJ, Nelemans PJ va boshqalar. Buyrak funksiyasini tomir ichi yodlangan konidan himoya qilish uchun profilaktik gidratatsiya 2016.

    file

    download